Tech Company Inital Public Offerings
Prevail Therapeutics IPO
Prevail Therapeutics was acquired by . The company's stock became public on 6/19/2019.
Transaction Overview
Company Name
Announced On
6/19/2019
Transaction Type
IPO
Amount
$110,000,000
Proceeds Purpose
We intend to use the net proceeds from this offering, together with our existing cash and cash equivalents: to advance the development of PR001, including to fund our planned Phase 1/2 trials for PR001 for the treatment of PD-GBA and neuronopathic Gaucher disease; to advance the development of PR006, including our ongoing preclinical studies for PR006 for the treatment of FTD-GRN; to advance the development of PR004, including our ongoing preclinical studies for PR004 for the treatment of synucleinopathies; and for working capital and general corporate purposes.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
430 East 29th St. 1520
New York, NY 10016
USA
New York, NY 10016
USA
Phone
Website
Email Address
Overview
Prevail Therapeutics is a biotech company based in New York City that is developing therapeutics for brain disorders such as Parkinson's disease. Prevail is establishing a pipeline of programs that includes discovery-phase and preclinical development efforts.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Asa Abeliovich
Chief Financial Officer
Brett Kaplan
Chief Medical Officer
Jeffrey Sevigny
Chief Technical Officer
Yong Dai
VP - Bus. Development
Franz Hefti
VP - Bus. Development
Emily Minkow
VP - General Counsel
Kira Schwartz
Browse more venture capital transactions:
Prev: 6/19/2019: SafeAI venture capital transaction
Next: 6/19/2019: Cleave Biosciences venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on all VC transactions involving tech companies. VC investment data records reported here are sourced from a variety of public sources. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs